343 related articles for article (PubMed ID: 28530660)
1. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.
Jin Y; Muhl L; Burmakin M; Wang Y; Duchez AC; Betsholtz C; Arthur HM; Jakobsson L
Nat Cell Biol; 2017 Jun; 19(6):639-652. PubMed ID: 28530660
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
3. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
4. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
[TBL] [Abstract][Full Text] [Related]
5. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
[TBL] [Abstract][Full Text] [Related]
6. Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells.
Zhang Q; Wang C; Cannavicci A; Faughnan ME; Kutryk MJB
Transl Res; 2021 Sep; 235():129-143. PubMed ID: 33894400
[TBL] [Abstract][Full Text] [Related]
7. Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.
Choi EJ; Chen W; Jun K; Arthur HM; Young WL; Su H
PLoS One; 2014; 9(2):e88511. PubMed ID: 24520391
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
Sugden WW; Siekmann AF
Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
[TBL] [Abstract][Full Text] [Related]
10. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of arteriovenous malformations in the absence of endoglin.
Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM
Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041
[TBL] [Abstract][Full Text] [Related]
13. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
14. Arterial endoglin does not protect against arteriovenous malformations.
Singh E; Redgrave RE; Phillips HM; Arthur HM
Angiogenesis; 2020 Nov; 23(4):559-566. PubMed ID: 32506200
[TBL] [Abstract][Full Text] [Related]
15. Defective Flow-Migration Coupling Causes Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Park H; Furtado J; Poulet M; Chung M; Yun S; Lee S; Sessa WC; Franco CA; Schwartz MA; Eichmann A
Circulation; 2021 Sep; 144(10):805-822. PubMed ID: 34182767
[TBL] [Abstract][Full Text] [Related]
16. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
[TBL] [Abstract][Full Text] [Related]
17. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
Snodgrass RO; Chico TJA; Arthur HM
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
[TBL] [Abstract][Full Text] [Related]
18. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
Sharma S; Ehrlich M; Zhang M; Blobe GC; Henis YI
Commun Biol; 2024 Jan; 7(1):112. PubMed ID: 38242992
[TBL] [Abstract][Full Text] [Related]
19. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
[TBL] [Abstract][Full Text] [Related]
20. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
